COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE Guzauskas, G., Wang, B. M., Pollom, E., Stieber, V. W., Garrison, L. OXFORD UNIV PRESS INC. 2018: 116–17

View details for Web of Science ID 000460646300488